173 related articles for article (PubMed ID: 23761661)
1. A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice.
Liu P; Shu Z; Qin X; Dou Y; Zhao Y; Zhao X
Clin Vaccine Immunol; 2013 Aug; 20(8):1246-54. PubMed ID: 23761661
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.
Sun J; Wei Y; Rauf A; Zhang Y; Ma Y; Zhang X; Shilo K; Yu Q; Saif YM; Lu X; Yu L; Li J
J Virol; 2014 Nov; 88(21):12348-63. PubMed ID: 25122790
[TBL] [Abstract][Full Text] [Related]
3. Experimental infection of adults with recombinant wild-type human metapneumovirus.
Talaat KR; Karron RA; Thumar B; McMahon BA; Schmidt AC; Collins PL; Buchholz UJ
J Infect Dis; 2013 Nov; 208(10):1669-78. PubMed ID: 23908489
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.
Lévy C; Aerts L; Hamelin MÈ; Granier C; Szécsi J; Lavillette D; Boivin G; Cosset FL
Vaccine; 2013 Jun; 31(25):2778-85. PubMed ID: 23583815
[TBL] [Abstract][Full Text] [Related]
5. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
[TBL] [Abstract][Full Text] [Related]
6. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
7. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
[TBL] [Abstract][Full Text] [Related]
8. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
9. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccines.
Aerts L; Rhéaume C; Carbonneau J; Lavigne S; Couture C; Hamelin MÈ; Boivin G
J Gen Virol; 2015 Apr; 96(Pt 4):767-774. PubMed ID: 25519171
[TBL] [Abstract][Full Text] [Related]
11. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
[TBL] [Abstract][Full Text] [Related]
12. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.
Kolli D; Bataki EL; Spetch L; Guerrero-Plata A; Jewell AM; Piedra PA; Milligan GN; Garofalo RP; Casola A
J Virol; 2008 Sep; 82(17):8560-9. PubMed ID: 18562525
[TBL] [Abstract][Full Text] [Related]
13. Replication and pathogenicity of attenuated human metapneumovirus F mutants in severe combined immunodeficiency mice.
Yu CM; Li RP; Chen X; Liu P; Zhao XD
Vaccine; 2012 Jan; 30(2):231-6. PubMed ID: 22085552
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.
Pilaev M; Shen Y; Carbonneau J; Venable MC; Rhéaume C; Lavigne S; Couture C; Guarné A; Hamelin MÈ; Boivin G
Vaccine; 2020 Feb; 38(9):2122-2127. PubMed ID: 32007293
[TBL] [Abstract][Full Text] [Related]
15. Live vaccines for human metapneumovirus designed by reverse genetics.
Buchholz UJ; Nagashima K; Murphy BR; Collins PL
Expert Rev Vaccines; 2006 Oct; 5(5):695-706. PubMed ID: 17181442
[TBL] [Abstract][Full Text] [Related]
16. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
17. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.
Alvarez R; Harrod KS; Shieh WJ; Zaki S; Tripp RA
J Virol; 2004 Dec; 78(24):14003-11. PubMed ID: 15564507
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a Mixture of Nucleoprotein from Human Metapneumovirus and AbISCO-100 Adjuvant Reduces Viral Infection in Mice Model.
Diaz-Dinamarca DA; Ibañez FJ; Soto DA; Soto JA; Cespedes PF; Muena NA; Garate DS; Kalergis AM; Vasquez AE
Viral Immunol; 2018 May; 31(4):306-314. PubMed ID: 29373084
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques.
Herfst S; Schrauwen EJ; de Graaf M; van Amerongen G; van den Hoogen BG; de Swart RL; Osterhaus AD; Fouchier RA
Vaccine; 2008 Aug; 26(33):4224-30. PubMed ID: 18585830
[TBL] [Abstract][Full Text] [Related]
20. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.
Williams JV; Tollefson SJ; Johnson JE; Crowe JE
J Virol; 2005 Sep; 79(17):10944-51. PubMed ID: 16103146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
